ofatumumab (arzerra) Report issue

Biologics mAb Orphan Drug FDA Approved FDA Accelerated Approval FDA
Back

Drug Pricing Summary

VA Big4

$86.6318 - $5154.9000

VA FSS

$120.0676 - $6812.4000

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
ofatumumab 20 mg / 0.4 mL (0.4 mL INJECTION) $5154.9000 VA Big4
  • KESIMPTA (1)
  • Novartis Pharmaceuticals Corporation
    ofatumumab 20 mg / 0.4 mL (0.4 mL INJECTION) $6812.4000 VA FSS
  • KESIMPTA (1)
  • Novartis Pharmaceuticals Corporation
    ofatumumab 20 mg / 1 mL (1 mL INJECTION) $86.6318 VA Big4
  • ARZERRA (50)
  • Novartis Pharmaceuticals Corporation
    ofatumumab 20 mg / 1 mL (1 mL INJECTION) $120.0676 VA FSS
  • ARZERRA (50)
  • Novartis Pharmaceuticals Corporation
    ofatumumab 20 mg / 1 mL (1 mL INJECTION) $262.4660 VA Big4
  • ARZERRA (5)
  • Novartis Pharmaceuticals Corporation
    ofatumumab 20 mg / 1 mL (1 mL INJECTION) $360.2040 VA FSS
  • ARZERRA (5)
  • Novartis Pharmaceuticals Corporation

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue